谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

First-line Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression: Real-World Data from a Spanish Multicenter Study

Aida Piedra,Sergio Martinez-Recio,Ainhoa Hernandez,Teresa Moran,Edurne Arriola, Jordi Recuero-Borau,Manuel Cobo,Patricia Cordeiro,Joaquin Mosquera, Manuel Fernandez,Rosario Garcia-Campelo,Antonio Calles,Rosa Alvarez,Maria Zapata-Garcia,Dolores Isla,Ana Callejo,Patricia Iranzo, Jorgina Serra-Lopez,Andres Barba,Ivana Sullivan,Enriqueta Felip,Margarita Majem

FRONTIERS IN ONCOLOGY（2024）

引用 0|浏览4
关键词
pembrolizumab,non-small cell lung cancer,first-line,predictive factors,high PD-L1 expression,immune check-point inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要